Suchergebnisse - "Ritonavir"

PubPharm (2.871)

1

The effect of ritonavir on the pharmacokinetics of clonidine in vivo and in vitro

enthalten in: Pakistan journal of pharmaceutical sciences | 2023

von Wang, P. | Hu, X.

2

Effectiveness of nirmatrelvir/ritonavir (Paxlovid®) in preventing hospitalisation and death among COVID-19 patients : a prospective cohort study

enthalten in: The Medical journal of Malaysia | 2023

von Chew, L. | Lim, X. | Chang, C. | +8

3

Is Azvudine Comparable to Nirmatrelvir-Ritonavir in Real-World Efficacy and Safety for Hospitalized Patients with COVID-19? A Retrospective Cohort Study

enthalten in: Infectious diseases and therapy | 2023

von Zhao, Q. | Zheng, B. | Han, B. | +15

4

Estimation of Intangible Costs for Factors Associated with Oral Antiviral Drugs for COVID-19 Treatment: A Conjoint Analysis in Japan

enthalten in: Advances in therapy | 2023

von Hosogaya, N. | Takazono, T. | Kurazono, K. | +5

5

An economically advantageous amorphous solid dispersion of the fixed combination of lopinavir and ritonavir

enthalten in: Journal of pharmaceutical investigation | 2023

von Yun, T. | Jung, M. | Bang, K. | +8

6

Physiologically-Based Pharmacokinetic Modeling of PAXLOVID™ with First-Order Absorption Kinetics

enthalten in: Pharmaceutical research | 2023

von Sagawa, K. | Lin, J. | Jaini, R. | +1

7

PRESTIGIO RING : "A 59-year-old HIV-1 positive, highly treatment-experienced woman failing darunavir/ ritonavir plus raltegravir"

enthalten in: The new microbiologica | 2023

von Labate, L. | Bruzzone, B. | Spagnuolo, V. | +4

8

Response to Comment on “Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin”

enthalten in: Journal of medical toxicology | 2023

von Sindelar, M. | McCabe, D. | Carroll, E.

9

Tacrolimus Drug–Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin

enthalten in: Journal of medical toxicology | 2022

von Sindelar, M. | McCabe, D. | Carroll, E.

10

Efficacy and Safety of Nirmatrelvir/Ritonavir, Molnupiravir, and Remdesivir in a Real-World Cohort of Outpatients with COVID-19 at High Risk of Progression: The PISA Outpatient Clinic Experience

enthalten in: Infectious diseases and therapy | 2022

von Tiseo, G. | Barbieri, C. | Galfo, V. | +23

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[288]